Skip to main content
  • En
  • Français

Top Navigation

  • Newsroom
  • Contact Us

Main navigation

  • About Us
  • Products
  • Technology
  • Clinical Studies
  • Investors
  • News
  • En
  • Français

2017

Bone Therapeutics Business Update for the Third Quarter of 2017

  • Read more about Bone Therapeutics Business Update for the Third Quarter of 2017

Annual Results 2016 conference call

  • Read more about Annual Results 2016 conference call

Presentation H1 2017 results

  • Read more about Presentation H1 2017 results

2017 Annual Report

  • Read more about 2017 Annual Report

3 vragen aan Thomas Lienard (Dutch)

  • Read more about 3 vragen aan Thomas Lienard (Dutch)

Thomas Lienard, Bone Therapeutics: "On va refinancer l'entreprise en faisant appel à des investisseurs" (French)

  • Read more about Thomas Lienard, Bone Therapeutics: "On va refinancer l'entreprise en faisant appel à des investisseurs" (French)

Bone Therapeutics Granted EUR 2.3 Million in Non-Dilutive Funding by the Walloon Region

  • Read more about Bone Therapeutics Granted EUR 2.3 Million in Non-Dilutive Funding by the Walloon Region

Bone Therapeutics Provides Business Update for Q4 2016

  • Read more about Bone Therapeutics Provides Business Update for Q4 2016

Bone Therapeutics réaffirme son éligibilité au PEA-PME pour 2017

  • Read more about Bone Therapeutics réaffirme son éligibilité au PEA-PME pour 2017

Bone Therapeutics Notice of Full Year 2016 Results

  • Read more about Bone Therapeutics Notice of Full Year 2016 Results

Pagination

  • Previous page ‹‹
  • Next page ››
Subscribe to 2017
Wallonie Eu Flag

BioSenic SA
Rue Granbonpré 11 – Bâtiment H (bte 24)
1435 Mont-St-Guibert – Belgium
T.: +32 493 09 73 66
info@biosenic.com
Contact

Sign upfor our press releases

Receive information about BioSenic

Sign Up

Footer menu

  • Privacy Policy
  • Trademarks Copyrights
  • Users conditions